Subsequent Events	9 Months Ended
Sep. 30, 2023
Subsequent Events
Subsequent Events	Note 8: Subsequent Events The Company changed its name to Stem Cell Inc. to better reflect its new business focus that gears towards stem cell based biotechnology and was approved by the Nevada Secretary of State on October 10, 2023. As of October 10, 2023, the Company has transitioned into a new business plan focused on commercializing stem cell based technology in the biotechnology sector witha specialty focus in regenerative medicine and discontinued all business activities related to mining royalties. On October 18, 2023, the Company entered into an agreement with Auto Stem Laboratories Limited to acquire an intellectual property asset for a stock consideration of two million shares of its common stock at $1 per share.

The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 855
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//855/tableOfContent

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 855
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483399/855-10-50-2

Name:	us-gaap_SubsequentEventsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration